Lawrence Mehren

Non-Executive Deputy Chairman, Non-Executive Director / Lumos Diagnostics Holdings

Mr Mehren has over 20 years' experience working in the diagnostics industry, in both operational and financial roles. Between 2007 and 2012 Lawrence served as CFO and then COO of Ventana Medical Systems, a global supplier of cancer diagnostics systems which was acquired by Roche in 2008. In 2012 Lawrence assisted in the re-launch of Accelerate Diagnostics, a company dedicated to modernizing disease diagnostics, which went public on NASDAQ in 2012. Lawrence served as President, CEO and Director of the company from 2012 to January 2020. He is also member of the Risk Committee of LDX.

Lists and Charts

Total Shareholder Return as at 05/02/26

Rank	Company	1 Yr	5 Yr
37^th	Auris Minerals	563.64%	-12.46%
38^th	EQ Resources	560.88%	35.79%
39^th	Lumos Diagnostics Holdings	552.11%	0%
40^th	Paterson Resources	550%	10.2%
41^st	Benz Mining	541.29%	15.06%

View Full List

1663 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Person Activity

NEW ROLE: Non-Executive Deputy Chairman, Non-Executive Director, Lumos Diagnostics Holdings

07 Apr 2022

Related Information

Access to our data for Lawrence Mehren is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Lawrence Mehren is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.